TSXV:EVE.H - Post by User
Post by
stwatcheron Jun 01, 2020 11:32am
298 Views
Post# 31096507
Newsletter
Newsletter LATEST NEWS FROM EVE & CO. | | | On behalf of the team at Eve & Co, we’d like to thank you for your support of Eve & Co and faith in our company. In our newsletter, we will be providing updates and addressing questions. As you know, Eve has one of the largest Cannabis production facilities in the world, and we are one of a handful of Canadian companies with EU-GMP certification. We remain the foremost female-oriented cannabis company in Canada with authentic female leadership and direction. We hope to maintain an open forum to share with our shareholders through this newsletter. | | | While we have received our EU-GMP certification, there are a number of steps to complete before our first shipments can be made. Shipments to Europe (Germany) are dependent on the Regulators in both countries issuing import and export permits. These permits do not exist as individual licenses but are – as the name suggests – a permit for export by Eve & Co and permit for import by the European distributor and these must be obtained for each individual shipment. In order for Eve & Co to request an export permit from Health Canada, it must first receive an import permit which has been obtained by the European distributor. As soon as this European import permit has been received by Eve & Co, all paperwork is then submitted to Health Canada for the export permit. Usually, Health Canada takes up to 6 to 8 weeks to issue an export permit. However, this timeline has been substantially increased given the COVID-19 pandemic. We are ready to start shipping product overseas once all these import and export approvals have been granted by both the Canadian and European regulators. | | AGM & Special Meeting Update | | The Eve & Co Incorporated annual and special meeting will be held on June 25th, 2020 at 11:00 am. In order to mitigate any risks to the health and safety of our community, shareholders, employees and other stakeholders, and consistent with current social distancing recommendations, the Meeting will be held in virtual-only format, conducted via live audio webcast. Registered shareholders and duly appointed proxyholders will be permitted to attend the meeting and vote, all in real time, provided they are connected to the internet and have logged in through their web browser at: https://web.lumiagm.com/201000707(password is EVE2020). You have to be connected to the internet at all times to be able to vote – it’s your responsibility to make sure you stay connected for the entire meeting. Please refer to the enclosed instructions to gain access to the Meeting through your web browser.
A Shareholder wishing to be represented by proxy at the Meeting or any adjournment or postponement thereof must deposit his, her or its duly executed form of proxy with the Corporation’s transfer agent and registrar, TSX Trust Company, Suite 301, 100 Adelaide Street West, Toronto, Ontario, M5H 4H1, on or before 11:00 a.m. on June 23, 2020.
Given that the Meeting will be conducted virtually, Shareholders are urged to sign, date and return the enclosed form of proxy in the envelope provided for that purpose. The record date for the determination of those Shareholders entitled to receive the Notice of Annual and Special Meeting of Shareholders and to vote at the Meeting was the close of business on May 11, 2020.
One of the agenda items for approval is to authorize the Company to file articles of amendment to give effect to a share consolidation, only if and when determined by the board of directors. A share consolidation can also be referred to as a reverse stock split and has the effect of reducing the total number of issued and outstanding shares while increasing the per share value for each shareholder proportionately. A shareholder will therefore hold fewer shares but each share will be worth proportionally more. The aggregate market value of those shares does not change; likewise the market capitalization of the Company. Should the share consolidation be approved by the shareholders, it does not mean that it will be immediately effected, but does give the board of directors the authority to do so as and when they determine that it will be in the interests of the Company to do so. | | | Pictures from Flowering Room 3 | | | |
| |
| |